AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3+
SponsorAevice Health Pte. Ltd.

About this trial

Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The subject is willing and/or parents/guardians are able to give informed consent for participation in the study.

Male or Female, aged ≥ 3 years.

Diagnosed with acute asthma exacerbation by an ED provider.

Disqualifiers

Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.

Trial population

Study will include 160 Subjects (80 Pediatrics and 80 Adult Subjects) who are presenting with wheeze in the emergency department, and outpatient and inpatient settings

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • AeviceMD

    Device

    The AeviceMD device will be placed on the patient to detect the presence of wheeze and perform auscultation.

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: Patients diagnosed with acute asthma exacerbation1 intervention
Group B: Patient with a non-cardiac AND non-pulmonary chief complaint and discharge diagnosis0 interventions

Trial outcomes

Primary outcomes

1

Wheeze is detected by physician and AeviceMD

Primary endpoint of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording.

Time frame
60 Seconds

Secondary outcomes

1

Respiratory sounds are detected and identified by onsite physician and offsite (remote) physician

Secondary endpoint of normal, abnormal and absent breath breath sounds will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation - i.e. bronchovesicular, crackles. Normal, abnormal and absent breath sounds will be annotated in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the independent physician during remote auscultation - i.e. bronchovesicular, crackles.

Time frame
150 Seconds

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aevice Health Pte. Ltd.

Lead sponsor

Montefiore Medical Center

Collaborator